Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?

Identifieur interne : 000490 ( Main/Exploration ); précédent : 000489; suivant : 000491

The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?

Auteurs : Cyrielle Holuka [Luxembourg (pays)] ; Myriam P. Merz [Luxembourg (pays)] ; Sara B. Fernandes [Luxembourg (pays)] ; Eleftheria G. Charalambous [Luxembourg (pays)] ; Snehaa V. Seal [Luxembourg (pays)] ; Nathalie Grova [Luxembourg (pays), France] ; Jonathan D. Turner [Luxembourg (pays)]

Source :

RBID : pubmed:32707661

Descripteurs français

English descriptors

Abstract

A poor socioeconomic environment and social adversity are fundamental determinants of human life span, well-being and health. Previous influenza pandemics showed that socioeconomic factors may determine both disease detection rates and overall outcomes, and preliminary data from the ongoing coronavirus disease (COVID-19) pandemic suggests that this is still true. Over the past years it has become clear that early-life adversity (ELA) plays a critical role biasing the immune system towards a pro-inflammatory and senescent phenotype many years later. Cytotoxic T-lymphocytes (CTL) appear to be particularly sensitive to the early life social environment. As we understand more about the immune response to SARS-CoV-2 it appears that a functional CTL (CD8+) response is required to clear the infection and COVID-19 severity is increased as the CD8+ response becomes somehow diminished or exhausted. This raises the hypothesis that the ELA-induced pro-inflammatory and senescent phenotype may play a role in determining the clinical course of COVID-19, and the convergence of ELA-induced senescence and COVID-19 induced exhaustion represents the worst-case scenario with the least effective T-cell response. If the correct data is collected, it may be possible to separate the early life elements that have made people particularly vulnerable to COVID-19 many years later. This will, naturally, then help us identify those that are most at risk from developing the severest forms of COVID-19. In order to do this, we need to recognize socioeconomic and early-life factors as genuine medically and clinically relevant data that urgently need to be collected. Finally, many biological samples have been collected in the ongoing studies. The mechanisms linking the early life environment with a defined later-life phenotype are starting to be elucidated, and perhaps hold the key to understanding inequalities and differences in the severity of COVID-19.

DOI: 10.3390/ijms21145094
PubMed: 32707661
PubMed Central: PMC7404093


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?</title>
<author>
<name sortKey="Holuka, Cyrielle" sort="Holuka, Cyrielle" uniqKey="Holuka C" first="Cyrielle" last="Holuka">Cyrielle Holuka</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Merz, Myriam P" sort="Merz, Myriam P" uniqKey="Merz M" first="Myriam P" last="Merz">Myriam P. Merz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fernandes, Sara B" sort="Fernandes, Sara B" uniqKey="Fernandes S" first="Sara B" last="Fernandes">Sara B. Fernandes</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Charalambous, Eleftheria G" sort="Charalambous, Eleftheria G" uniqKey="Charalambous E" first="Eleftheria G" last="Charalambous">Eleftheria G. Charalambous</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Seal, Snehaa V" sort="Seal, Snehaa V" uniqKey="Seal S" first="Snehaa V" last="Seal">Snehaa V. Seal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32707661</idno>
<idno type="pmid">32707661</idno>
<idno type="doi">10.3390/ijms21145094</idno>
<idno type="pmc">PMC7404093</idno>
<idno type="wicri:Area/Main/Corpus">000851</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000851</idno>
<idno type="wicri:Area/Main/Curation">000851</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000851</idno>
<idno type="wicri:Area/Main/Exploration">000851</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?</title>
<author>
<name sortKey="Holuka, Cyrielle" sort="Holuka, Cyrielle" uniqKey="Holuka C" first="Cyrielle" last="Holuka">Cyrielle Holuka</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Merz, Myriam P" sort="Merz, Myriam P" uniqKey="Merz M" first="Myriam P" last="Merz">Myriam P. Merz</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fernandes, Sara B" sort="Fernandes, Sara B" uniqKey="Fernandes S" first="Sara B" last="Fernandes">Sara B. Fernandes</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Charalambous, Eleftheria G" sort="Charalambous, Eleftheria G" uniqKey="Charalambous E" first="Eleftheria G" last="Charalambous">Eleftheria G. Charalambous</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Seal, Snehaa V" sort="Seal, Snehaa V" uniqKey="Seal S" first="Snehaa V" last="Seal">Snehaa V. Seal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette</wicri:regionArea>
<wicri:noRegion>L-4345 Esch-sur-Alzette</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">International journal of molecular sciences</title>
<idno type="eISSN">1422-0067</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (immunology)</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Disease Susceptibility (immunology)</term>
<term>Healthcare Disparities (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Risk Factors (MeSH)</term>
<term>Social Class (MeSH)</term>
<term>Socioeconomic Factors (MeSH)</term>
<term>Stress, Psychological (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (immunologie)</term>
<term>Classe sociale (MeSH)</term>
<term>Disparités d'accès aux soins (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Facteurs socioéconomiques (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Prédisposition aux maladies (immunologie)</term>
<term>Stress psychologique (immunologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Infections à coronavirus</term>
<term>Lymphocytes T CD8+</term>
<term>Pneumopathie virale</term>
<term>Prédisposition aux maladies</term>
<term>Stress psychologique</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Betacoronavirus</term>
<term>CD8-Positive T-Lymphocytes</term>
<term>Coronavirus Infections</term>
<term>Disease Susceptibility</term>
<term>Pneumonia, Viral</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Healthcare Disparities</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Risk Factors</term>
<term>Social Class</term>
<term>Socioeconomic Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Classe sociale</term>
<term>Disparités d'accès aux soins</term>
<term>Facteurs de risque</term>
<term>Facteurs socioéconomiques</term>
<term>Humains</term>
<term>Pandémies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A poor socioeconomic environment and social adversity are fundamental determinants of human life span, well-being and health. Previous influenza pandemics showed that socioeconomic factors may determine both disease detection rates and overall outcomes, and preliminary data from the ongoing coronavirus disease (COVID-19) pandemic suggests that this is still true. Over the past years it has become clear that early-life adversity (ELA) plays a critical role biasing the immune system towards a pro-inflammatory and senescent phenotype many years later. Cytotoxic T-lymphocytes (CTL) appear to be particularly sensitive to the early life social environment. As we understand more about the immune response to SARS-CoV-2 it appears that a functional CTL (CD8+) response is required to clear the infection and COVID-19 severity is increased as the CD8+ response becomes somehow diminished or exhausted. This raises the hypothesis that the ELA-induced pro-inflammatory and senescent phenotype may play a role in determining the clinical course of COVID-19, and the convergence of ELA-induced senescence and COVID-19 induced exhaustion represents the worst-case scenario with the least effective T-cell response. If the correct data is collected, it may be possible to separate the early life elements that have made people particularly vulnerable to COVID-19 many years later. This will, naturally, then help us identify those that are most at risk from developing the severest forms of COVID-19. In order to do this, we need to recognize socioeconomic and early-life factors as genuine medically and clinically relevant data that urgently need to be collected. Finally, many biological samples have been collected in the ongoing studies. The mechanisms linking the early life environment with a defined later-life phenotype are starting to be elucidated, and perhaps hold the key to understanding inequalities and differences in the severity of COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32707661</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>08</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>08</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1422-0067</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
<Day>19</Day>
</PubDate>
</JournalIssue>
<Title>International journal of molecular sciences</Title>
<ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E5094</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21145094</ELocationID>
<Abstract>
<AbstractText>A poor socioeconomic environment and social adversity are fundamental determinants of human life span, well-being and health. Previous influenza pandemics showed that socioeconomic factors may determine both disease detection rates and overall outcomes, and preliminary data from the ongoing coronavirus disease (COVID-19) pandemic suggests that this is still true. Over the past years it has become clear that early-life adversity (ELA) plays a critical role biasing the immune system towards a pro-inflammatory and senescent phenotype many years later. Cytotoxic T-lymphocytes (CTL) appear to be particularly sensitive to the early life social environment. As we understand more about the immune response to SARS-CoV-2 it appears that a functional CTL (CD8+) response is required to clear the infection and COVID-19 severity is increased as the CD8+ response becomes somehow diminished or exhausted. This raises the hypothesis that the ELA-induced pro-inflammatory and senescent phenotype may play a role in determining the clinical course of COVID-19, and the convergence of ELA-induced senescence and COVID-19 induced exhaustion represents the worst-case scenario with the least effective T-cell response. If the correct data is collected, it may be possible to separate the early life elements that have made people particularly vulnerable to COVID-19 many years later. This will, naturally, then help us identify those that are most at risk from developing the severest forms of COVID-19. In order to do this, we need to recognize socioeconomic and early-life factors as genuine medically and clinically relevant data that urgently need to be collected. Finally, many biological samples have been collected in the ongoing studies. The mechanisms linking the early life environment with a defined later-life phenotype are starting to be elucidated, and perhaps hold the key to understanding inequalities and differences in the severity of COVID-19.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Holuka</LastName>
<ForeName>Cyrielle</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Merz</LastName>
<ForeName>Myriam P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fernandes</LastName>
<ForeName>Sara B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Charalambous</LastName>
<ForeName>Eleftheria G</ForeName>
<Initials>EG</Initials>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Seal</LastName>
<ForeName>Snehaa V</ForeName>
<Initials>SV</Initials>
<Identifier Source="ORCID">0000-0002-9297-4616</Identifier>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grova</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Calbinotox, Faculty of Science and Technology, Lorraine University, 54506 Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Jonathan D</ForeName>
<Initials>JD</Initials>
<Identifier Source="ORCID">0000-0002-2760-1071</Identifier>
<AffiliationInfo>
<Affiliation>Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, L-4345 Esch-sur-Alzette, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>C12/BM/3985792 "EpiPath"</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>C19/SC/13650569 "ALAC"</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>C16/BM/11342695 "MetCOEPs"</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>INTER/ANR/16/11568350 "MADAM"</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>PRIDE/11012546/NEXTIMMUNE</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>PRIDE17/11823097/MicrOH</GrantID>
<Agency>Fonds National de la Recherche Luxembourg</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>CA18211</GrantID>
<Agency>European Cooperation in Science and Technology</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>CA16120</GrantID>
<Agency>European Cooperation in Science and Technology</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>07</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Int J Mol Sci</MedlineTA>
<NlmUniqueID>101092791</NlmUniqueID>
<ISSNLinking>1422-0067</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012923" MajorTopicYN="Y">Social Class</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">early life adversity</Keyword>
<Keyword MajorTopicYN="N">health inequalities</Keyword>
<Keyword MajorTopicYN="N">immune exhaustion</Keyword>
<Keyword MajorTopicYN="N">immunosenescence</Keyword>
<Keyword MajorTopicYN="N">psychosocial stress</Keyword>
<Keyword MajorTopicYN="N">socioeconomic status</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>06</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>07</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32707661</ArticleId>
<ArticleId IdType="pii">ijms21145094</ArticleId>
<ArticleId IdType="doi">10.3390/ijms21145094</ArticleId>
<ArticleId IdType="pmc">PMC7404093</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Curr Probl Pediatr Adolesc Health Care. 2011 Jul;41(6):158-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21684471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2019 Mar;77:168-177</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30639443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2020 Apr 16;15(4):e0230295</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32298273</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32217835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20578-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23184974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care. 2020 Mar 18;24(1):108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32188484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine. 2017 Aug;96:87-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28390266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17046-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18955703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Epidemiol. 1996 Sep;6(5):442-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8915476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2013 Nov 13;14(5):559-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24237701</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Inflamm Res. 2016 Apr 27;9:51-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27175089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Dev Orig Health Dis. 2010 Feb;1(1):26-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20198106</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Pathol. 2010;5:99-118</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20078217</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Immunol. 2013 Apr;25(2):214-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23298609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 Mar 05;18(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28273875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>SN Compr Clin Med. 2020 Apr 15;:1-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32296757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2020 May 04;12(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32375305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2009 Oct 16;31(4):677-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19833089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2019 May 28;11(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31141915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32085846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2016 Nov;58:248-253</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27470228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Dis Child. 1999 Apr;80(4):305-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10086930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cardiovasc Dev Dis. 2016 Nov 29;3(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29367575</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci. 2007 Aug 15;27(33):8857-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17699667</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viral Immunol. 2003;16(2):141-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12828866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Public Health. 2010;31:329-47 3p following 347</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20070189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2015 Mar;53:233-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25638481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Epidemiol Community Health. 2020 Aug;74(8):620-623</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32385126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychosom Med. 2017 Jun;79(5):514-523</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28178032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2011 Aug 05;11(9):625-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21818124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Jun 29;4(6):e6074</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19562079</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Apr;26(4):453-455</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32284614</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Psychogeriatr. 2016 Mar;28(3):405-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26265356</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2020 Aug;81(2):e16-e25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32335169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 Sep 21;478(7368):250-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21937990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2963-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19188604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Behav Med. 2018 Aug;41(4):568-570</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29802534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Psychiatry. 2016 Jun;21(6):738-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27090305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2002 Jul 25;347(4):240-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12140299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2018 Sep 12;24(3):364-378.e6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30212649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Epigenetics. 2019 Sep 3;11(1):131</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31481107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2009 Jan;64(1):38-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19001005</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Metabolism. 2012 Nov;61(11):1633-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22607770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2019 Mar 13;10(3):249</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30867412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Apr 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32293753</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Acad Nutr Diet. 2020 Apr;120(4):565-586</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31473156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Reprod Med. 2009 Sep;27(5):358-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19711246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2016 May 3;315(17):1899-901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27139064</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2019 Dec 19;15(12):e1008109</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31856206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2020 Apr;162:108125</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32224164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2020 May;163:108186</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32360400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2009 Nov 1;18(21):4046-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19656776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Endocrine. 2018 Oct;62(1):116-128</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30032404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Pulmonol. 2018 Jun;53(6):696-697</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29667347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Heart Assoc. 2020 May 18;9(10):e015855</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32410481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Neurosci. 2005 May;8(5):555-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15856062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Res. 2020 May 30;188:109754</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32526492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2009 Oct 22;14(42):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19883543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2018 May;15(5):506-517</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28392574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Biol. 2007;8(9):R189</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17854483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 2018 Sep;1428(1):151-169</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30011075</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genome Med. 2010 Feb 24;2(2):14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20236494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2006 Jul;20(4):339-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16289758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14716-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19617551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Dis. 2011 Oct;2(5):382-397</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22308228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2020 Jun;46(6):1294-1297</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Clin Respir J. 2018 Aug 01;5(1):1487214</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30128088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>SSM Popul Health. 2018 Feb 07;4:189-196</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29854904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chronic Dis Transl Med. 2018 Jun 07;4(2):75-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29988883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2017 Oct 17;8:1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29089944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2002 Aug 31;360(9334):659-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12241871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Sep 5;501(7465):112-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23965619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Ther. 2020 Jun;42(6):964-972</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32362344</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Early Hum Dev. 2006 Aug;82(8):485-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16876341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16757-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20855592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Jul;26(7):1077-1083</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32405028</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2020 Apr;162:108142</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32278764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 2):S95-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10988160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dis Markers. 2011;30(2-3):123-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21508516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Pulmonol. 2018 Jun;53(6):710-719</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29528197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 1991 Oct 26;303(6809):1019-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1954451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stress. 2014 Mar;17(2):133-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24417382</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Technol Assess. 2019 Jan;23(2):1-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30675873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mucosal Immunol. 2020 Jul;13(4):691-701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32047272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Total Environ. 2020 Aug 10;729:138919</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32353720</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2018 Nov 30;9(1):5091</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30504906</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hum Genet. 2007 Aug;81(2):338-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17668382</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rev Med Microbiol. 2019 Jan;30(1):1-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30662163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2020 Apr 29;21(9):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32365612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 Dec 15;199(12):4046-4055</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29133294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Genomics. 2019 Jan 14;2019:2085496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30733955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioessays. 2007 Feb;29(2):145-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17226802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Perinatol. 2013 Jul;33(7):558-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23328927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Pathol. 2020 Jun 8;154(1):23-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32441303</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2013 Sep;38(9):1858-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23838101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Total Environ. 2020 Jul 20;727:138704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32315904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Psychiatry. 2018 Sep 04;9:420</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30233435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2018 Jan 23;15(1):e1002494</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29360829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 May 9;497(7448):258-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23624374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Public Health Rep. 2006;121 Suppl 1:191-204; discussion 190</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16550779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2020 Jul;20(7):442-447</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32528136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2016 May;67:153-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26897704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2020 May 01;11:827</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32425950</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2029-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27001848</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 2020 Aug 1;254:117808</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32422305</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Essays Biochem. 2018 Dec 2;62(5):643-723</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30509934</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 2;395(10234):1421-1422</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330427</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Behav Immun. 2013 Nov;34:31-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23845919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Comp Immunol. 2020 Jul;108:103672</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32151677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wien Klin Wochenschr. 2020 Jul;132(13-14):356-361</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32435867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Behav Neurosci. 2014 May 22;8:192</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24904343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Amino Acids. 2015 Apr;47(4):693-705</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25534429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2020 May;163:108151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32305399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Health Soc Behav. 2010;51 Suppl:S28-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20943581</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Sep 19;9(9):e107653</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25238154</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 2019 Aug;197(2):205-213</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31251396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2020 May;163:108146</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32283128</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2019 Sep;76(18):3479-3496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31049600</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Syst. 2015 Jul 29;1(1):51-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26251845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viral Immunol. 2005;18(1):41-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15802953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurosci Biobehav Rev. 1988 Summer;12(2):123-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3050629</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Psychopathol. 2020 Aug;32(3):853-863</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31407649</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine Growth Factor Rev. 2020 Jun;53:25-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32446778</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Surg. 2020 Apr;76:128-129</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32169574</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3080-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21300872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Stress. 2011 May;14(3):335-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21438770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenetics. 2015;10(8):749-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26098974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2020 May;17(5):541-543</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32203186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2008 Aug 15;64(4):266-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18440494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1976 Aug;104(2):107-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">782233</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Gen Psychiatry. 1996 Jan;53(1):25-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8540774</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Investig Med. 2011 Aug;59(6):881-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21527855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Jul 25;487(7408):477-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22837003</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 2015 Oct;45(14):2975-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26219269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Behav Neurosci. 2009 Aug 24;3:14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19738918</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Apr 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32293639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2019 Oct;574(7776):117-121</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31534227</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol. 2020 Jul;216:108464</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32405269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2015 May 13;17(5):577-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25974300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tob Induc Dis. 2020 Mar 20;18:20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32206052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Immunol. 2016 Nov;1(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28664195</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 2012 Feb 15;71(4):366-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22088795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Endocrinol Invest. 2020 Jun 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32557271</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32105632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Immunol. 2020 Jun;17(6):650-652</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32346099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32278065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2014 Dec 24;6(268):268ra179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25540326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epigenetics. 2015;10(10):958-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26295359</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Int. 2020 Jul;140:105790</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32388248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Mar 5;180(5):847-861.e15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142678</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 Jan 15;198(2):557-563</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28069750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Intern Med. 2020 May;75:107-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32192856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Abuse Negl. 2018 Nov;85:137-144</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29859639</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychoneuroendocrinology. 2017 Aug;82:140-154</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28549270</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Luxembourg (pays)</li>
</country>
<region>
<li>Grand Est</li>
<li>Lorraine (région)</li>
</region>
<settlement>
<li>Nancy</li>
</settlement>
</list>
<tree>
<country name="Luxembourg (pays)">
<noRegion>
<name sortKey="Holuka, Cyrielle" sort="Holuka, Cyrielle" uniqKey="Holuka C" first="Cyrielle" last="Holuka">Cyrielle Holuka</name>
</noRegion>
<name sortKey="Charalambous, Eleftheria G" sort="Charalambous, Eleftheria G" uniqKey="Charalambous E" first="Eleftheria G" last="Charalambous">Eleftheria G. Charalambous</name>
<name sortKey="Fernandes, Sara B" sort="Fernandes, Sara B" uniqKey="Fernandes S" first="Sara B" last="Fernandes">Sara B. Fernandes</name>
<name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
<name sortKey="Merz, Myriam P" sort="Merz, Myriam P" uniqKey="Merz M" first="Myriam P" last="Merz">Myriam P. Merz</name>
<name sortKey="Seal, Snehaa V" sort="Seal, Snehaa V" uniqKey="Seal S" first="Snehaa V" last="Seal">Snehaa V. Seal</name>
<name sortKey="Turner, Jonathan D" sort="Turner, Jonathan D" uniqKey="Turner J" first="Jonathan D" last="Turner">Jonathan D. Turner</name>
</country>
<country name="France">
<region name="Grand Est">
<name sortKey="Grova, Nathalie" sort="Grova, Nathalie" uniqKey="Grova N" first="Nathalie" last="Grova">Nathalie Grova</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000490 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000490 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32707661
   |texte=   The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32707661" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021